Pharma Stocks

Regulatory setback, sharp drop and rising short interest

Vanda Pharmaceuticals shares came under heavy pressure after a regulatory setback announcement and are now facing rising short interest. What…

Read More »

A Look At Amylyx Pharmaceuticals (AMLX) Valuation After Recent Share Price Volatility

Why Amylyx Pharmaceuticals Stock Is On Investors’ Radar Amylyx Pharmaceuticals (AMLX) has drawn fresh attention after recent trading saw the…

Read More »

option deal boosts global Alzheimer’s ambition

Shanghai Fosun Pharmaceutical has agreed to pay up to USD 240 million more for global rights to AriBio’s experimental Alzheimer’s…

Read More »

buyback, earnings momentum and fresh highs draw investor

Aurobindo Pharma Ltd has completed a sizeable share buyback and continues to post growing profits, while the stock trades near…

Read More »

Bayer News On Camelina Alliance And Cardiac Imaging Progress At A Discount

Bayer (XTRA:BAYN) announced a major alliance with bp to commercialize camelina as a renewable fuel feedstock. The company reported positive…

Read More »

Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results

Traws Pharma, Inc. Private financing of up to $60M offering of common stock (with $10M upfront) and milestone-based warrants expected…

Read More »

Rajesh Palviya of Axis Sec suggests Ajanta Pharma, Tata Communications, NMDC shares to buy today – 15 May

Stock market today: Benchmark equity indices Sensex and Nifty 50 opened higher on Friday, 15 May, supported by gains in…

Read More »

Vertex Pharmaceuticals (VRTX) Is Up 6.0% After New ESOP Shelf, CASGEVY Deal And Guidance Reaffirmation

In early May 2026, Vertex Pharmaceuticals filed a new US$2.87 billion shelf registration for 6,400,000 common shares tied to its employee…

Read More »

Doximity Flags Pharma Ad Market Weakness – Doximity (NYSE:DOCS)

Doximity, an operator of an online networking service for medical professionals, reported fourth-quarter revenue of $145.4 million, up 5% year…

Read More »

Latest financials and China pharma exposure

Sinopharm Group Co Ltd, China’s leading pharmaceutical distributor, reported trailing twelve-month revenue of CNY 332.22 billion as of recent data,…

Read More »